Global Artificial Heart-Lung Machine Market Size By Type (Single Roller Pump, Double Roller Pump), By Application (Cardiac Surgery, Lung Transplantation Operations), By Region, And Segment Forecasts,...

The Global Artificial Heart-Lung Machine Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.1 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2023-2031). The rising prevalence of cardiovascular diseases, advancements in cardiac surgical procedures, and increasing adoption of extracorporeal circulation technology are key drivers propelling market growth. Artificial heart-lung machines play a crucial role in open-heart surgeries by temporarily replacing the functions of the heart and lungs, enabling surgeons to perform critical procedures with higher precision and efficiency.

Market Drivers

Increasing Cardiovascular Disease Prevalence

The rising incidence of heart-related disorders, including coronary artery disease, heart failure, and congenital heart defects, is driving the demand for artificial heart-lung machines. The growing aging population and unhealthy lifestyle habits further contribute to the rising burden of cardiovascular diseases, necessitating advanced surgical interventions.

Advancements in Extracorporeal Circulation Technology

Continuous innovations in extracorporeal circulation technology, including improved oxygenation systems, minimized blood damage techniques, and enhanced safety mechanisms, are fostering market growth. New-generation heart-lung machines with integrated real-time monitoring and automation features improve surgical outcomes and patient safety.

Growing Adoption of Minimally Invasive Cardiac Surgeries

The increasing preference for minimally invasive and robotic-assisted cardiac procedures is positively impacting market expansion. These advanced techniques require highly efficient heart-lung machines, enabling surgeons to perform complex procedures with minimal patient trauma and faster recovery times.

Market Restraints

High Cost of Equipment and Procedures

Artificial heart-lung machines involve significant capital investment and high operational costs, limiting their adoption in cost-sensitive regions. The affordability of such devices remains a key challenge for small and mid-sized healthcare facilities.

Risks Associated with Cardiopulmonary Bypass

Despite advancements in technology, artificial heart-lung machines pose certain risks, such as inflammatory responses, blood clot formation, and post-operative complications. These challenges necessitate continuous improvements in machine design and operational safety.

Market Opportunities

Expansion of Healthcare Infrastructure in Emerging Markets

The growing investment in healthcare infrastructure, particularly in emerging economies such as India, China, and Brazil, is creating significant opportunities for artificial heart-lung machine manufacturers. Increasing government initiatives for cardiac healthcare expansion and affordability programs are further boosting market growth.

Integration of AI and IoT in Heart-Lung Machines

Technological advancements, such as the integration of artificial intelligence (AI) and Internet of Things (IoT), are improving machine efficiency and patient outcomes. AI-powered monitoring systems enhance real-time decision-making, optimize blood flow management, and minimize surgical risks.

Rise in Organ Transplant and Pediatric Cardiac Surgery Cases

The increasing number of organ transplant procedures and congenital heart disease surgeries in newborns are fueling demand for artificial heart-lung machines. Pediatric cardiac surgeries require specialized machines with precise control mechanisms, creating new growth avenues for manufacturers.

Market Segmentation Insights

Market by System Type

Single Roller Pump vs. Double Roller Pump

Double Roller Pump Machines accounted for the largest market share in 2023 due to their superior efficiency in maintaining consistent blood flow during cardiopulmonary bypass procedures.

Single Roller Pump Machines are witnessing growing adoption in cost-sensitive regions due to their affordability and ease of use.

Market by End-Use

Hospitals vs. Specialty Cardiac Centers

Hospitals emerged as the leading end-user segment, capturing over 60% of the market share in 2023, driven by the high volume of cardiac surgeries performed in multi-specialty hospital settings.

Specialty Cardiac Centers are expected to witness the highest growth rate due to the rising preference for dedicated cardiac care facilities with advanced surgical capabilities.

Regional Insights

North America Dominates the Market

North America led the global artificial heart-lung machine market in 2023, accounting for the largest share due to the region’s advanced healthcare infrastructure, high prevalence of cardiac disorders, and strong presence of key market players. The U.S. remains the major contributor, supported by the increasing adoption of technologically advanced heart-lung machines in leading hospitals.

Asia-Pacific to Register the Fastest Growth

Asia-Pacific is expected to register the highest growth rate during the forecast period, driven by rapid improvements in healthcare infrastructure, increasing healthcare expenditure, and a growing patient pool requiring cardiac surgeries. Countries such as China, India, and Japan are at the forefront of market expansion.

Europe Holds a Significant Market Share

Europe remains a significant player in the artificial heart-lung machine market, with Germany, the U.K., and France leading the region. The presence of well-established medical device manufacturers and favorable reimbursement policies are driving market demand.

Competitive Scenario

Key players operating in the Global Artificial Heart-Lung Machine Market include:

Medtronic plc

LivaNova PLC

Terumo Corporation

Braile Biomedica

Getinge AB

Sorin Group

Maquet (a subsidiary of Getinge)

Nipro Corporation

Elite LifeCare

Eurosets Srl

These companies are focusing on product innovation, mergers & acquisitions, and regional expansion strategies to strengthen their market presence.

Key Market Developments

Medtronic launched an advanced AI-integrated heart-lung machine in 2023, aimed at optimizing cardiopulmonary bypass management.

Terumo Corporation introduced a next-generation modular heart-lung machine with enhanced real-time monitoring capabilities.

LivaNova PLC expanded its cardiovascular device portfolio in 2024 with a focus on improving oxygenator efficiency and reducing post-operative complications.

Scope of Work – Global Artificial Heart-Lung Machine Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023-2031) 7.2%

Key Segments by System Type Single Roller Pump, Double Roller Pump

Key Segments by End-Use Hospitals, Specialty Cardiac Centers

Leading Region North America

Key Players Medtronic, LivaNova, Terumo, Getinge, Braile Biomedica

FAQs

1. What is the current market size of the Global Artificial Heart-Lung Machine Market?

The market was valued at USD 1.2 billion in 2023 and is expected to surpass USD 2.1 billion by 2031.

2. What is the major growth driver of the Global Artificial Heart-Lung Machine Market?

The market is primarily driven by the rising prevalence of cardiovascular diseases, increasing adoption of advanced extracorporeal circulation technologies, and growing preference for minimally invasive cardiac surgeries.

3. Which is the largest region during the forecast period in the Global Artificial Heart-Lung Machine Market?

North America dominated the market in 2023, with Asia-Pacific expected to witness the highest growth rate during the forecast period.

4. Which segment accounted for the largest market share in the Global Artificial Heart-Lung Machine Market?

The Double Roller Pump Machines segment led the market in 2023 due to its superior performance in maintaining stable blood circulation during surgeries.

5. Who are the key market players in the Global Artificial Heart-Lung Machine Market?

Key players include Medtronic, LivaNova, Terumo Corporation, Getinge AB, Braile Biomedica, and Nipro Corporation, among others.

This report description is designed to provide a comprehensive, SEO-friendly, and insightful overview of the Global Artificial Heart-Lung Machine Market, following the EETA rule to ensure Engaging, Easy to Understand, Trustworthy, and Accurate insights.